Hints and tips:
Related Special Reports
Related Topics
...The Wellcome Trust was founded in 1936 after the death of pharmaceutical entrepreneur Sir Henry Wellcome, founder of one of the predecessors to drugmaker GlaxoSmithKline....
...Pfizer will also have the opportunity to sell out of its consumer health joint venture with GlaxoSmithKline when it lists in London as Haleon this summer....
...GlaxoSmithKline said its potential new blockbuster shot for respiratory syncytial virus appears to be more effective than rival Pfizer’s vaccine candidate, as the pair compete for a new market protecting...
...Peltz had built a stake in the early months of 2022, after Unilever’s share price slumped following its botched attempt to buy GlaxoSmithKline’s consumer healthcare arm, later spun out as Haleon....
...Sanofi and GlaxoSmithKline have reported promising results from trials of their Covid-19 vaccine, which has proved to be particularly effective against the Omicron strain....
...Haleon, GlaxoSmithKline’s consumer healthcare venture with Pfizer, is down about 5 per cent from its July listing price....
...Late last year, GlaxoSmithKline’s Pakistan unit stopped producing painkiller Panadol, saying that higher material prices were incurring “heavy financial losses”....
...GlaxoSmithKline has raised its yearly profit and sales guidance for the second quarter in a row after beating analysts’ expectations for the three months to September....
...GlaxoSmithKline owns the painkiller brand Panadol, not Nurofen as incorrectly stated in an article on January 20....
...GlaxoSmithKline will apply for approval for its respiratory syncytial virus vaccine for older adults, after reporting data showing the shot is the first to work in the vulnerable age group for the major...
...Emma Walmsley, GlaxoSmithKline’s chief executive who has been under pressure from activist investors, has promised a “step change in growth” in 2022, as the UK drugmaker beat earnings expectations in the...
...GlaxoSmithKline: shingle minded Worried about shingles? GlaxoSmithKline is....
...GlaxoSmithKline’s chief executive said a shareholder vote in favour of spinning off its consumer healthcare business vindicated the UK drugmaker’s decision to turn down a £50bn takeover offer from Unilever...
...Corporate earnings: Airbus, BASF, Breedon, British American Tobacco, Carrefour, Credit Suisse, Danone, Deutsche Bank, Deutsche Börse, Equinor, GlaxoSmithKline, Holcim, Iberdrola, Mercedes-Benz, Millennium...
...GlaxoSmithKline has reached an agreement to buy blood cancer specialist Sierra Oncology for £1.5bn as part of plans to strengthen its drug pipeline after pressure from activist investors....
...Pharmaceuticals group Sanofi has reported positive results from a Covid-19 booster vaccine that it has developed with GlaxoSmithKline....
...GlaxoSmithKline will apply for approval for its respiratory syncytial virus vaccine for older adults, after reporting positive data showing the shot is the first to work in the vulnerable age group for the...
...Pfizer will sell down its stake in Haleon, its consumer health joint venture with GlaxoSmithKline, after a London listing planned for July 18....
...Unilever expects the strongest cost inflation in decades to hit profitability for two years, adding to pressure on chief executive Alan Jope, who ruled out large acquisitions after a failed bid for GlaxoSmithKline...
...GlaxoSmithKline will acquire Boston-based biotech Affinivax in a transaction worth up to $3.3bn, as it seeks to bolster its vaccines business with a new technology....
...Its failed attempts to buy UK drugmaker GlaxoSmithKline’s consumer healthcare business, a politically fraught fight with Ben & Jerry’s and the arrival of the billionaire activist Nelson Peltz on Unilever...
...Now, pharmaceutical companies including Sanofi and GlaxoSmithKline, as well as the Covid mRNA vaccine makers, are trialling other shots, such as annual influenza vaccines, using the technology....
...The merged word reflects GlaxoSmithKline’s optimism about its soon-to-be demerged consumer business....
...Sanofi and GlaxoSmithKline have reported promising results from trials of their Covid-19 vaccine, which has proved to be particularly effective against the Omicron strain of coronavirus....
...Sanofi and GlaxoSmithKline’s next generation Covid-19 vaccine could be used as a booster, after new data suggested that it elicited a strong immune response against the Omicron variant....
International Edition